We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
90 hedge funds and large institutions have $66.9M invested in Invesco Pharmaceuticals ETF in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
1% more funds holding
Funds holding: 89 → 90 (+1)
2% more capital invested
Capital invested by funds: $65.8M → $66.9M (+$1.09M)
0.03% less ownership
Funds ownership: 18.22% → 18.19% (-0.03%)
63% less call options, than puts
Call options by funds: $322K | Put options by funds: $869K
Holders
90
Holders Change
+1
Holders Change %
+1.12%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
25
Reduced
20
Closed
6
Calls
$322K
Puts
$869K
Net Calls
-$547K
Net Calls Change
+$470K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.05M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.01M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$823K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$698K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$397K |
